S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

INBX Inhibrx Biosciences Inc

16.90

0.38 (2.30%)

Pre Market

Last Updated: 06:53:11

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Inhibrx Biosciences (NASDAQ:INBX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Inhibrx Biosciences Charts.

Inhibrx Biosciences (NASDAQ:INBX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Inhibrx Biosciences Charts.

Inhibrx Inc News

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
Thursday 14 November 2024 (2 months ago) • PR Newswire (US)

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
Monday 4 November 2024 (2 months ago) • PR Newswire (US)

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Tuesday 13 August 2024 (5 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 28 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 24 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 May 2024 (7 months ago) • Edgar (US Regulatory)

More Inhibrx Inc News Articles

TPT Global Tech (CE)

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Valiant Eagle (PK)

Good Vibrations Shoes (PK)

Moon Equity (PK)

Federal Home Loan Mortgage (QB)

Ubiquitech Software (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions